Ranexa and Ninlaro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranexa (ranolazine) and Ninlaro (ixazomib citrate). Common drug interactions include diarrhoea among females and neuropathy peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Ranexa and Ninlaro. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.

What is Ninlaro?

Ninlaro has active ingredients of ixazomib citrate. eHealthMe is studying from 19,563 Ninlaro users. Check the latest studies of Ninlaro.



On Jul, 13, 2026

19 people who take Ranexa and Ninlaro together, and have interactions are studied.

Ranexa and Ninlaro drug interactions.

What are the common drug interactions of Ranexa and Ninlaro, by gender? *:

female:

  1. Diarrhoea
  2. Abdominal distension
  3. Arthropathy
  4. Constipation
  5. Herpes zoster
  6. Migraine (headache)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Abdominal discomfort
  9. Alopecia (absence of hair from areas of the body)
  10. Faecaloma (hard mass of fecal matter)

male:

  1. Neuropathy peripheral (surface nerve damage)
  2. Cardiac failure congestive
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Full blood count decreased
  6. Influenza
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Neuralgia (pain in one or more nerves)
  9. Pain in extremity
  10. Red blood cell count decreased

What are the common drug interactions of Ranexa and Ninlaro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal distension
  2. Constipation
  3. Diarrhoea
  4. Herpes zoster
  5. Migraine (headache)
  6. Tremor (trembling or shaking movements in one or more parts of your body)

60+:

  1. Fall
  2. Cardiac failure congestive
  3. Influenza
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Pruritus (severe itching of the skin)
  6. Pubis fracture
  7. Red blood cell count decreased
  8. Concussion (short loss of normal brain function in response to a head injury)
  9. Head injury
  10. Loss of consciousness

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 19 people, 100.00%
  2. Pain: 2 people, 10.53%
  3. Hypersensitivity: 2 people, 10.53%
  4. Nausea And Vomiting: 1 person, 5.26%
  5. Nausea (feeling of having an urge to vomit): 1 person, 5.26%
  6. Dyspnea (difficult or laboured breathing): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ranexa and Ninlaro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranexa and Ninlaro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ninlaro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ninlaro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranolazine and ixazomib citrate (the active ingredients of Ranexa and Ninlaro, respectively), and Ranexa and Ninlaro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: